ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Nephroprotective and antioxidant properties of a novel herbal extract combination in a high-fat diet and alloxan-induced kidney injury in rats

OK Yulizal, Darmadi Darmadi, OK Ikram Alchair, Encik Nazifa Zanzabilla Putri, Wa Amalia Zahiah, Tesalonika Apmarda Simarmata.



Abstract
Download PDF Post

Objectives: The present study investigated the therapeutic effects of a standardized capsule combination consisting of Channa striata, Phyllanthus niruri L., and Curcuma xanthorrhiza extracts (CCE) on biomarkers of kidney function, antioxidant status, and kidney histopathology in a high-fat diet (HFD) and alloxan-induced diabetic/nephrotoxic rat model.
Materials and Methods: Male Wistar rats (n = 24) were divided into 4 groups: Control; HFD + alloxan treatment (diabetics/nephrotoxic); diabetics/nephrotoxic + CCE (49.5 mg/kg BW); diabetic/nephrotoxic + CCE + pioglitazone treatment group (1.35 mg/kg BW). Serum Cystatin C, superoxide dismutase (SOD) activity, and kidney histopathology were assessed at Day 60.
Results: Model induction markedly increased blood glucose, HbA1c, and serum Cystatin C levels and decreased SOD activity (p < 0.001 vs controls). CCE significantly attenuated cystatin C by decreasing Cystatin C by 18.2% (p < 0.001) and restored SOD activity to 94.0% of control (p < 0.001). Histopathology showed marked improvements in glomerular hypertrophy, tubular injury, vascular congestion, and inflammatory infiltration (p < 0.001 vs model). CCE + pioglitazone showed comparable biochemical trends and enhanced histological preservation.
Conclusions: CCE combination significantly attenuated diabetic/nephrotoxic-induced kidney injury by improving antioxidant defense and preserving kidney structure. This suggests therapeutic potential for managing metabolic kidney complications.

Key words: Cystatin C; herbal medicine; nephroprotection; oxidative stress; superoxide dismutase







Bibliomed Article Statistics

15
R
E
A
D
S

6
D
O
W
N
L
O
A
D
S
05
2026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.